|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001563,
umls-concept:C0003873,
umls-concept:C0025677,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0036043,
umls-concept:C0205177,
umls-concept:C0205210,
umls-concept:C0282462,
umls-concept:C0443315,
umls-concept:C1274040,
umls-concept:C1707455,
umls-concept:C2587213
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2008-1-21
|
|
pubmed:abstractText |
To compare the efficacy and safety of subcutaneous (SC) versus oral administration of methotrexate (MTX) in patients with active rheumatoid arthritis (RA).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
pubmed-author:BrandtAA,
pubmed-author:BraunJJ,
pubmed-author:DemaryWW,
pubmed-author:FlaxenbergPP,
pubmed-author:Guimbal-SchmolckCC,
pubmed-author:HankePP,
pubmed-author:HeitzWW,
pubmed-author:KästnerPP,
pubmed-author:MC-MTX.6/RH Study Group,
pubmed-author:PichlmeierUU,
pubmed-author:RockwitzKK,
pubmed-author:WährischJJ,
pubmed-author:von HinüberUU
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
58
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
73-81
|
|
pubmed:dateRevised |
2008-11-13
|
|
pubmed:meshHeading |
pubmed-meshheading:18163521-Administration, Oral,
pubmed-meshheading:18163521-Adult,
pubmed-meshheading:18163521-Aged,
pubmed-meshheading:18163521-Antirheumatic Agents,
pubmed-meshheading:18163521-Arthritis, Rheumatoid,
pubmed-meshheading:18163521-Double-Blind Method,
pubmed-meshheading:18163521-Female,
pubmed-meshheading:18163521-Humans,
pubmed-meshheading:18163521-Injections, Subcutaneous,
pubmed-meshheading:18163521-Male,
pubmed-meshheading:18163521-Methotrexate,
pubmed-meshheading:18163521-Middle Aged,
pubmed-meshheading:18163521-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial.
|
|
pubmed:affiliation |
Rheumazentrum Ruhrgebiet, Herne, Germany. J.Braun@rheumazentrum-ruhrgebiet.de
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase IV
|
